Algorithm for Evaluation and Medical Management Strategy for the ACS Patient
Algorithm for Evaluation and Medical Management Strategy for the ACS Patient - Flowchart Algorithm for Evaluation and Medical Management Strategy for the ACS Patient Algorithm for Evaluation and Medical Management Strategy for the ACS Patient
«Flowchart»

ACUTE CORONARY SYNDROME

ACUTE CORONARY SYNDROME

ACUTE CORONARY SYNDROME

ACUTE CORONARY SYNDROME

SYMPTOMS may include: Substernal chest, jaw, arm or neck pain or discomfort (pain may or may not radiate), generalized weakness, sweating, lightheaded, N/V, shortness of breath, hypo/hypertension, pulmonary edema, IVD, cool / clammy skin, S3, S4, new onset LBBB

SYMPTOMS may include: Substernal chest, jaw, arm or neck pain or discomfort (pain may or may not radiate), generalized weakness, sweating, lightheaded, N/V, shortness of breath, hypo/hypertension, pulmonary edema, IVD, cool / clammy skin, S3, S4, new onset LBBB

SYMPTOMS may include SYMPTOMS

12-Lead EKG within 10 minutes of arrival: If not diagnostic, continue serial EKG Q15-30min for first hour

12-Lead EKG within 10 minutes of arrival: If not diagnostic, continue serial EKG Q15-30min for first hour

12-Lead EKG within 10 minutes of arrival 12-Lead EKG

STABILIZE / Support ABC’s
Oxygen (O2 Sal <90%, resp distress, risk)
Continuous EKG Monitor—treatment arrhythmias, Vital Signs, IV Access, Brief History & complete fibrinolytic checklist, Draw Labs (cardiac biomarkers, CBC, electrolytes, renal, coagulation studies, CRP, etc.), Chest X-Ray

STABILIZE / Support ABC’s
Oxygen (O2 Sal <90%, resp distress, risk)
Continuous EKG Monitor—treatment arrhythmias, Vital Signs, IV Access, Brief History & complete fibrinolytic checklist, Draw Labs (cardiac biomarkers, CBC, electrolytes, renal, coagulation studies, CRP, etc.), Chest X-Ray

STABILIZE / Support ABC’s
2
STABILIZE / Support ABC’s

End

End

End

Reperfusion Strategy

Percutaneous coronary intervention (PCI) with reperfusion— 90 minutes of STEMI diagnosis optimal
If PCI >120 minutes or PCI not available, consider fibrinolytics, give within 10 minites of diagnosis, transfer to PCI center

Reperfusion Strategy

Percutaneous coronary intervention (PCI) with reperfusion— 90 minutes of STEMI diagnosis optimal
If PCI >120 minutes or PCI not available, consider fibrinolytics, give within 10 minites of diagnosis, transfer to PCI center

Reperfusion Strategy

Reperfusion Strategy

Percutaneous coronary intervention (PCI) with reperfusion— 90 minutes of STEMI diagnosis optimal
If PCI >120 minutes or PCI not available, consider fibrinolytics, give within 10 minites of diagnosis, transfer to PCI center


Suspected ongoing ischemia, consider angiography with 2 hours of assessment

Suspected ongoing ischemia, consider angiography with 2 hours of assessment

Suspected ongoing ischemia, consider angiography with 2 hours of assessment

UNSTABLE ANGINA
ST Segment / T Wave normal or undiagnostic

UNSTABLE ANGINA
ST Segment / T Wave normal or undiagnostic

UNSTABLE ANGINA
UNSTABLE ANGINA

NSTEMI (Non-ST-segment elevation MI)
ST segment depression and/or T-Wave inversion—Elevated Cardiac Biomarkers

NSTEMI (Non-ST-segment elevation MI)
ST segment depression and/or T-Wave inversion—Elevated Cardiac Biomarkers

NSTEMI Non-ST-segment elevation MI
NSTEMI

STEMI (ST-segment elevation MI)
ST elevation / LBBB or RBBB & Ischemic symptoms—Elevated Cardiac Biomarkers

STEMI (ST-segment elevation MI)
ST elevation / LBBB or RBBB & Ischemic symptoms—Elevated Cardiac Biomarkers

STEMI ST-segment elevation MI
STEMI

Medication Management / Invasive Intervention(s)

Antithrombotic, pain relieving measures, other support medications such as: Nitrates Opioids, Anxiolytics, Aspirin, Beta Blockers, Calcium Channel Blockers, Statins
Anticoagulant: Unfractionated Heparin (Heparin)
P2Y (12) Platelet inhibitors: Brilinta
Platelet Aggregation Inhibitors: Plavix Effient
GP IIb/IIIa (glycoprotein) Antagonist Platelet Aggregation Inhibitors: Reopro, Integrillin, Aggrastat
LMWHS—Fragmin, Lovenox
Selective Factors Xa Inhibitor Anticoagulant: Xarello, Arixtra
Fibrinolytics (Thrombolytic): TNKase, Activase
Cardiogenic Shock—Pressor / inotropic agents such as dopamine, dobutamine, etc,
Intra-aortic pump for LV dysfunction / Emergent PCI prep and postprocedure care

Medication Management / Invasive Intervention(s)

Antithrombotic, pain relieving measures, other support medications such as: Nitrates Opioids, Anxiolytics, Aspirin, Beta Blockers, Calcium Channel Blockers, Statins
Anticoagulant: Unfractionated Heparin (Heparin)
P2Y (12) Platelet inhibitors: Brilinta
Platelet Aggregation Inhibitors: Plavix Effient
GP IIb/IIIa (glycoprotein) Antagonist Platelet Aggregation Inhibitors: Reopro, Integrillin, Aggrastat
LMWHS—Fragmin, Lovenox
Selective Factors Xa Inhibitor Anticoagulant: Xarello, Arixtra
Fibrinolytics (Thrombolytic): TNKase, Activase
Cardiogenic Shock—Pressor / inotropic agents such as dopamine, dobutamine, etc,
Intra-aortic pump for LV dysfunction / Emergent PCI prep and postprocedure care

Medication Management / Invasive Intervention(s)

Medication Management / Invasive Intervention(s)

Antithrombotic, pain relieving measures, other support medications such as: Nitrates Opioids, Anxiolytics, Aspirin, Beta Blockers, Calcium Channel Blockers, Statins
Anticoagulant: Unfractionated Heparin (Heparin)
P2Y (12) Platelet inhibitors: Brilinta
Platelet Aggregation Inhibitors: Plavix Effient
GP IIb/IIIa (glycoprotein) Antagonist Platelet Aggregation Inhibitors: Reopro, Integrillin, Aggrastat
LMWHS—Fragmin, Lovenox
Selective Factors Xa Inhibitor Anticoagulant: Xarello, Arixtra
Fibrinolytics (Thrombolytic): TNKase, Activase
Cardiogenic Shock—Pressor / inotropic agents such as dopamine, dobutamine, etc,
Intra-aortic pump for LV dysfunction / Emergent PCI prep and postprocedure care

Antithrombotic, pain relieving measures, other support medications such as
Anticoagulant
P2Y (12) Platelet inhibitors
Platelet Aggregation Inhibitors
GP IIb/IIIa (glycoprotein) Antagonist Platelet Aggregation Inhibitors

Selective Factors Xa Inhibitor Anticoagulant
Fibrinolytics (Thrombolytic):
Pressor / inotropic agents